Cardiac safety and potential efficacy: two reasons for considering minocycline in place of azithromycin in COVID-19 management.
Eur Heart J Cardiovasc Pharmacother
; 7(3): e53-e54, 2021 05 23.
Article
in En
| MEDLINE
| ID: mdl-32379302
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
COVID-19 Drug Treatment
/
Minocycline
/
Anti-Bacterial Agents
Limits:
Humans
Language:
En
Journal:
Eur Heart J Cardiovasc Pharmacother
Year:
2021
Document type:
Article